Tetracycline is a broad spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria. It exerts a bacteriostatic effect on bacteria by binding reversible to the bacterial 30S ribosomal subunit and blocking incoming aminoacyl tRNA from binding to the ribosome acceptor site. It also binds to some extent to the bacterial 50S ribosomal subunit and may alter the cytoplasmic membrane causing intracellular components to leak from bacterial cells. The FDA withdrew its approval for the use of all liquid oral drug products formulated for pediatric use containing tetracycline in a concentration greater than 25 mg/ml.[L43942] Other formulations of tetracycline continue to be used.
Bismuth Subcitrate Potassium, Metronidazole and Tetracycline Hydrochloride
Tetracyte Topical
TETRACYTE TOPICAL tetracycline hydrochloride
Acnecycline
Tetracycline 1% Ophthalmic Ointment
Vitastem-tetracycline hydrochloride
TETRACYTE TOPICAL - tetracycline hydrochloride
Tetracycline 3 percent a First Aid Antibiotic
Achromycin V
Abrasa
Achromycin Ont Oph 1%
Tetracycline-ABC
Tetracycline Hydrochloride
Pylera
Dyabetex
Medicycline Cap 250mg
FIRST Marys Mouthwash Compounding
Anistem
Apo Tetra Tabs 250mg
Actisite
Indication
Used to treat bacterial infections such as Rocky Mountain spotted fever, typhus fever, tick fevers, Q fever, rickettsialpox and Brill-Zinsser disease. May be used to treat infections caused by Chlamydiae spp., B. burgdorferi (Lyme disease), and upper respiratory infections caused by typical (S. pneumoniae, H. influenzae, and M. catarrhalis) and atypical organisms (C. pneumoniae, M. pneumoniae, L. pneumophila). May also be used to treat acne. Tetracycline may be an alternative drug for people who are allergic to penicillin.
Categories
Agents that produce neuromuscular block (indirect)
Alimentary Tract and Metabolism
Anti-Bacterial Agents
Anti-Infective Agents
Antibacterials for Systemic Use
Antibiotics for Topical Use
Antiinfectives and Antiseptics for Local Oral Treatment
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682